Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
65
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-248
45
COVID-19 in donation and transplant39
Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician35
Systemic absorption of liposomal inhaled amikacin in the treatment of resistant Mycobacterium avium: beyond expectations27
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León27
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker20
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain20
Successful rezafungin treatment of an azole-resistant Candida parapsilosis vascular graft infection20
COVID-19: Impact on prescribing and antimicrobial resistance19
Cefiderocol19
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences18
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project18
Is Propionimicrobium lymphophilum a new urinary tract infection cause?17
Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)16
Persistence and viability of SARS-CoV-2 in primary infection and reinfections16
Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications16
0.05814790725708